| scholarly article | Q13442814 |
| P2093 | author name string | Kafait U Malik | |
| Bahar Tunctan | |||
| Belma Korkmaz | |||
| C Kemal Buharalioglu | |||
| John Falck | |||
| Seyhan Sahan-Firat | |||
| Tuba Cuez | |||
| P2860 | cites work | Nitric oxide and vascular reactivity in sepsis. | Q46428848 |
| Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats. | Q46804513 | ||
| 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase | Q48493776 | ||
| Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. | Q53624128 | ||
| Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. | Q54277924 | ||
| A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock. | Q54461995 | ||
| Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. | Q54583287 | ||
| Does 20-hydroxyeicosatetraenoic acid contribute to sex differences in cardiovascular risk by increasing oxidative stress? | Q57216536 | ||
| 20-HETE agonists and antagonists in the renal circulation | Q57220278 | ||
| Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries | Q57220836 | ||
| Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide | Q57221409 | ||
| Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysacchride treatment in vivo in the rat | Q61712889 | ||
| 20-hydroxyeicosatetraenoic acid is an endothelium-dependent vasoconstrictor in rabbit arteries | Q70781584 | ||
| Cytochrome P450-derived renal HETEs: storage and release | Q73423928 | ||
| 20-HETE relaxes bovine coronary arteries through the release of prostacyclin | Q74132575 | ||
| Inhibition of extracellular signal-regulated kinase (ERK1/2) activity reverses endotoxin-induced hypotension via decreased nitric oxide production in rats | Q80380690 | ||
| Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension | Q80428271 | ||
| Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase | Q24307745 | ||
| Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel | Q28189283 | ||
| Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression | Q28243109 | ||
| Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice: a pro-inflammatory role for eNOS-derived no in vivo | Q28505758 | ||
| P-450 metabolites of arachidonic acid in the control of cardiovascular function | Q29620578 | ||
| The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling | Q31838704 | ||
| 20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. | Q34276074 | ||
| Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites | Q34428688 | ||
| Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system | Q34463893 | ||
| Functional significance of hsp90 complexes with NOS and sGC in endothelial cells | Q34653954 | ||
| 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. | Q34729787 | ||
| Regulation of the expression of inducible nitric oxide synthase. | Q35605774 | ||
| Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors | Q36138113 | ||
| Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies | Q36203883 | ||
| Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes | Q36698125 | ||
| Nitric oxide in shock | Q36835542 | ||
| Endothelial nitric oxide (NO) and its pathophysiologic regulation | Q36992714 | ||
| A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats. | Q37041257 | ||
| Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. | Q37199203 | ||
| Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. | Q40185278 | ||
| Effects of a 20-HETE antagonist and agonists on cerebral vascular tone | Q42457671 | ||
| Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. | Q42484284 | ||
| Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries | Q44138643 | ||
| Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. | Q44315300 | ||
| 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase | Q44353853 | ||
| Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats | Q44396063 | ||
| In the rostral ventrolateral medulla, the 70-kDa heat shock protein (HSP70), but not HSP90, confers neuroprotection against fatal endotoxemia via augmentation of nitric-oxide synthase I (NOS I)/protein kinase G signaling pathway and inhibition of NO | Q44671163 | ||
| Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus | Q44739223 | ||
| autoregulatory role of endothelium-derived nitric oxide (NO) on Lipopolysaccharide-induced vascular inducible NO synthase expression and function. | Q45176603 | ||
| Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. | Q45819815 | ||
| Negative feedback regulation of endothelial cell function by nitric oxide | Q46053566 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endotoxins | Q319997 |
| P304 | page(s) | 378-388 | |
| P577 | publication date | 2009-12-07 | |
| P1433 | published in | Basic and Clinical Pharmacology and Toxicology | Q15724438 |
| P1476 | title | A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats | |
| P478 | volume | 106 |
| Q37085844 | 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation. |
| Q47348893 | Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock. |
| Q40792305 | Contribution of PPARα/β/γ, AP-1, importin-α3, and RXRα to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat model of septic shock |
| Q37138417 | Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock |
| Q35084210 | Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats. |
| Q34151380 | Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKKβ/IκB-α/NF-κB pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock. |
| Q51025124 | Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms. |
| Q37174392 | NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite |
| Q35173157 | Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide |
| Q35710923 | Protection by 20-5,14-HEDGE against surgically induced ischemia reperfusion lung injury in rats. |
| Q38100223 | Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy. |
Search more.